Here, we systematically investigated the profiles and clinical relevance of the Tyro3 autoantibody in new-onset and treatment-naïve SLE patients and further explored the implications of this about the efferocytosis by macrophages. The gene discussed is TYRO3; the disease is systemic lupus erythematosus.